VB-08 / Vincere Biosci 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  VB-08 / Vincere Biosci
    ENCHANCEMENT OF MITOPHAGY VIA USP30 INHIBITION AS A THERAPEUTIC STRATEGY FOR ACUTE KIDNEY INJURY (SAT-025; Exhibition Hall and Main Foyer) -  Mar 8, 2024 - Abstract #ISNWCN2024ISN_WCN_620;    
    These findings highlight Vincere's USP30 inhibitor molecules potential in AKI treatment and as a prophylactic measure against CKD progression. The mitophagy-enhancing ability, coupled with selectivity and favorable pharmacological profile present a promising therapeutic approach in AKI management and CKD prevention.
  • ||||||||||  USP30 Inhibitor / Vincere Biosci
    VB-08: A SMALL MOLECULE INHIBITOR OF USP30 THAT ENHANCES MITOPHAGY (On-Demand Oral Gallery D) -  Dec 23, 2022 - Abstract #ADPD2023ADPD_791;    
    Here, we report a novel USP30 inhibitor, VB - 08... VB-08 presents a useful tool to test the effect of increased mitophag y in rodent models of neurodegeneration and sets the stage for translational development of a new and promising class of compounds for PD.